BioTech/Drugs - Newark, Delaware, US
SDIX, a wholly owned subsidiary of OriGene Technologies specializing in high quality, large-scale, GMP antibody production. All sites are ISO13485:2016 certified and FDA registered. Products include critical immunoreagents such as Troponin I, Strep A, CRP, Apo A1, ApoB, Micro-albumin, Immunoglobulins as well as Human Serum Calibrators. SDIX’s services include antiserum development and production in a variety of species as well as large-scale monoclonal and Polyclonal antibody production
Woo Commerce
Outlook
WordPress.org
Flywheel
Mobile Friendly
Google Analytics